Nuclear mechanics and mechanotransduction in muscular laminopathies
Nuclear mechanics and mechanotransduction in muscular laminopathies
批准号:
7337348
负责人:
Jan Lammerding
金额:
$25.8万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-01-01 至 2011-12-31
关键词:
AnimalsApoptosisBiomedical EngineeringBiopsyCell NucleusCell SurvivalCellsCharcot-Marie-Tooth DiseaseChromatinCytoplasmDefectDilated CardiomyopathyDiseaseEmbryoEmery-Dreifuss Muscular DystrophyEnvironmentEukaryotic CellFamilial partial lipodystrophyFibroblastsFunctional disorderGene Expression RegulationGenesGoalsHumanLamin Type ALeadLimb-Girdle Muscular DystrophiesLinkMeasuresMechanicsMethodsMolecularMolecular Biology TechniquesMusMuscleMuscle CellsMuscle FibersMuscular DystrophiesMutant Strains MiceMutationMyoblastsMyopathyNecrosisNormal tissue morphologyNuclearNuclear EnvelopeNuclear StructurePathway interactionsPatientsPhenotypeProteinsRangeRegulationResearch PersonnelSignal PathwaySignal TransductionSkinStriated MusclesTechniquesTestingTissuesTranscriptional Regulationbaseemerinenv Gene Productshuman diseaseimprovedinsightmouse modelnovelprogramsresponsetool
中文摘要
描述(由申请人提供):细胞核是真核细胞的显著特征,并通过核膜与周围的细胞质分离。核被膜蛋白核纤层蛋白A/C和Emerin中的突变引起Emery-Dreifuss型肌营养不良、肢带型肌营养不良、家族性部分脂肪营养不良和被称为核纤层蛋白病的多种其他疾病。潜在的疾病机制尚不清楚,部分原因是核膜蛋白的功能尚未完全确定。我的长期目标是了解这些普遍表达的蛋白质突变导致组织特异性表型的分子机制。该建议的中心主题是,肌肉特异性表型产生于核膜功能的特定异常,从受损的结构功能到异常的转录调控,导致适应性和保护性途径受损。我的具体目标是:1。表征与Emery-Dreifuss肌营养不良症相关的突变对核稳定性和细胞对机械应变敏感性的特定影响。使用最近建立的技术,我将测试的假设,从埃默里-德赖富斯肌营养不良症患者的皮肤成纤维细胞有专门受损的核稳定性和机械敏感基因的异常调节,导致应变下细胞活力下降。来自家族性部分脂肪营养不良患者和健康对照受试者的细胞将分别作为非特异性缺陷和正常核膜功能的对照。2.确定这些突变对核力学和基因调控的肌肉特异性影响。为了检验核稳定性和机械转导中的组织特异性缺陷有助于Emery-Dreifuss肌营养不良症中的肌肉表型的假设,我将比较来自Emery-Dreifuss肌营养不良症小鼠模型的肌细胞与来自相同动物的成纤维细胞和来自野生型同窝仔的细胞中的核力学、应变诱导的基因调控和应变下的细胞活力。研究这些突变的特定细胞缺陷将有助于提高我们对核膜正常和组织特异性功能的理解,并导致对Emery-Dreifuss肌营养不良症和其他核纤层蛋白病(如肢带型肌营养不良症)的分子机制的新见解,可能为治疗这些疾病提供新的靶点。
英文摘要
DESCRIPTION (provided by applicant): The nucleus is the distinguishing feature of eukaryotic cells and is separated from the surrounding cytoplasm by the nuclear envelope. Mutations in the nuclear envelope proteins lamin A/C and emerin cause Emery- Dreifuss muscular dystrophy, limb-girdle muscular dystrophy, familial partial lipodystrophy, and a variety of other diseases referred to as laminopathies. The underlying disease mechanism is unclear, in part because the function of the nuclear envelope proteins is incompletely defined. My long term goal is to understand the molecular mechanism(s) by which mutations in these ubiquitously expressed proteins can lead to such tissue-specific phenotypes. The central theme of this proposal is that muscle-specific phenotypes arise from specific abnormalities in nuclear envelope function, ranging from impaired structural function to abnormal transcriptional regulation, resulting in impaired adaptive and protective pathways. My specific aims are to: 1. Characterize the specific effects of mutations linked to Emery-Dreifuss muscular dystrophy on nuclear stability and cellular sensitivity to mechanical strain. Using recently established techniques, I will test the hypothesis that skin fibroblasts from Emery-Dreifuss muscular dystrophy patients have specifically impaired nuclear stability and abnormal regulation of mechanosensitive genes, resulting in decreased cell viability under strain. Cells from familial partial lipodystrophy patients and healthy control subjects will serve as controls for non-specific defects and normal nuclear envelope function, respectively. 2. Identify the muscle-specific effects of these mutations on nuclear mechanics and gene regulation. To test the hypothesis that tissue-specific defects in nuclear stability and mechanotransduction contribute to the muscular phenotype in Emery-Dreifuss muscular dystrophy, I will compare nuclear mechanics, strain- induced gene regulation, and cell viability under strain in muscle cells derived from mouse models of Emery- Dreifuss muscular dystrophy with fibroblasts from the same animals and with cells from wild-type littermates. Studying the specific cellular defects of these mutations will help to improve our understanding of normal and tissue-specific functions of the nuclear envelope and lead to new insights into the molecular mechanisms responsible for Emery-Dreifuss muscular dystrophy and other laminopathies such as limb-girdle muscular dystrophy, potentially providing new targets for the treatment of these diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2022 Intermediate Filaments Gordon Research Conference and Seminar
-
批准号:10469043
-
项目类别:
-
资助金额:$3.37万
-
财政年份:2022
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration
-
批准号:10389559
-
项目类别:
-
资助金额:$8.74万
-
财政年份:2021
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration
-
批准号:10642130
-
项目类别:
-
资助金额:$4.35万
-
财政年份:2020
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration (Equipment Supplement 2023)
-
批准号:10796133
-
项目类别:
-
资助金额:$16.0万
-
财政年份:2020
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration
-
批准号:10350671
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2020
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration
-
批准号:10574624
-
项目类别:
-
资助金额:$31.42万
-
财政年份:2020
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanobiology in confined migration
-
批准号:10724706
-
项目类别:
-
资助金额:$8.7万
-
财政年份:2020
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:8413555
-
项目类别:
-
资助金额:$7.94万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:9067464
-
项目类别:
-
资助金额:$40.25万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:7196846
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear-cytoskeletal coupling in muscular laminopathies
-
批准号:8044806
-
项目类别:
-
资助金额:$2.11万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:8842171
-
项目类别:
-
资助金额:$39.65万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:10215599
-
项目类别:
-
资助金额:$49.39万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:8576308
-
项目类别:
-
资助金额:$38.08万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:10413905
-
项目类别:
-
资助金额:$49.39万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear-cytoskeletal coupling in muscular laminopathies
-
批准号:7290147
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear mechanics and mechanotransduction in muscular laminopathies
-
批准号:7575151
-
项目类别:
-
资助金额:$25.8万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear-cytoskeletal coupling in muscular laminopathies
-
批准号:7796669
-
项目类别:
-
资助金额:$26.14万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear-cytoskeletal coupling in muscular laminopathies
-
批准号:7489316
-
项目类别:
-
资助金额:$26.4万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
Nuclear-cytoskeletal coupling in muscular laminopathies
-
批准号:7582243
-
项目类别:
-
资助金额:$25.88万
-
财政年份:2007
-
负责人:Jan Lammerding
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: